In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent

Michele Baccarani, Ilaria Iacobucci, Sabina Chiaretti, Robin Foà’, Poonkuzhali Balasubramanian, Elisabeth Paietta, Letizia Foroni, Sabine Jeromin, Barbara Izzo, Orietta Spinelli, Neelam Varma, Samia Menif, Carolina Terragna, Tulika Seth, Audrey Bidet, Daniel Coriu, Francesca Lunghi, Jiri Mayer, Barbara Scappini, Stephen LangabeerJacqueline Maier, Emma Burt, Anna Candoni, Francesco Albano, Mario Luppi, Irena Zupan, Thomas Lion, Renata Zadro, Francesco di Raimondo, Behzad Poopak, Giovanna Rege-Cambrin, Mario Annunziata, Ana Ayala, Victor Salinas-Viedma, Ana Ines Prado, Benedict Milner, Sara Galimberti, Jeroen Janssen, Valentina Polli, Lorenzo Comba, Beatrice Borsellino, Ombretta Annibali, Monica Crugnola, Francesco Passamonti

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)929-931
Number of pages3
JournalLeukemia
Volume34
Issue number3
DOIs
StatePublished - Mar 1 2020

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Baccarani, M., Iacobucci, I., Chiaretti, S., Foà’, R., Balasubramanian, P., Paietta, E., Foroni, L., Jeromin, S., Izzo, B., Spinelli, O., Varma, N., Menif, S., Terragna, C., Seth, T., Bidet, A., Coriu, D., Lunghi, F., Mayer, J., Scappini, B., ... Passamonti, F. (2020). In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent. Leukemia, 34(3), 929-931. https://doi.org/10.1038/s41375-019-0591-9